Siga technologies (siga) shares tumble after mpox therapy fails, chief medical officer terminated - hagens berman

San francisco, nov. 08, 2024 (globe newswire) -- biopharmaceutical company siga technologies is under intense scrutiny over its prior disclosures regarding the potential expansion of its lead product, tpoxx®, to treat mpox.

SIGA Ratings Summary

SIGA Quant Ranking